Symbols / MRAI $0.25 -7.04% Marpai, Inc.

Healthcare • Healthcare Plans • United States • OQX
MRAI Chart
O: — H: — L: — C: — V: —
SMA 20: SMA 50: SMA 200:
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Healthcare Plans
CEO Mr. Damien Francis Lamendola
Exch · Country OQX · United States
Market Cap 6.35M
Enterprise Value 35.24M
Income -16.56M
Sales 18.10M
FCF (ttm) -2.67M
Book/sh -1.35
Cash/sh 0.01
Employees 107
Insider 10d
IPO Oct 27, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E
Forward P/E -0.66
PEG
P/S 0.35
P/B -0.19
P/C
EV/EBITDA -2.76
EV/Sales 1.95
Quick Ratio 0.04
Current Ratio 0.40
Debt/Eq
LT Debt/Eq
EPS (ttm) -2.71
EPS next Y -0.38
EPS Growth
Revenue Growth -39.50%
EPS Gr Q/Q
Rev Gr Q/Q
Earnings (next) 2026-05-13
Earnings (prior) 2024-05-09
ROA -71.14%
ROE
ROIC
Gross Margin 26.41%
Oper. Margin -123.04%
Profit Margin -91.50%
Shs Outstand 25.29M
Shs Float 14.92M
Insider Own 47.03%
Instit Own 4.07%
Short Float 0.24%
Short Ratio 0.11
Short Interest 11.51K
52W High 1.78
vs 52W High -85.90%
52W Low 0.21
vs 52W Low 16.74%
Beta 4.36
Impl. Vol.
Rel Volume 0.11
Avg Volume 60.48K
Volume 6.74K
Target (mean)
Tgt Median
Tgt Low
Tgt High
# Analysts
Recom None
Prev Close $0.27
Price $0.25
Change -7.04%
About

Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company provides third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also offers in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company provides health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus Mean price target
2. Current target Latest analyst target
3. DCF / Fair value Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.25
Low
High
Mean

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-03-28 up Maxim Group Hold → Buy $6
2023-11-15 down Maxim Group Buy → Hold
2023-11-14 down Maxim Group Buy → Hold
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-19 SHIV SAGIV Director 100,000 $0.00 $0
2025-11-07 EITAN YARON I Director 100,000 $1.42 $141,500
2025-11-07 PONS ROBERT M Director 50,000 $1.42 $70,750
2025-11-07 SHIV SAGIV Director 50,000 $1.42 $70,750
2025-11-07 SCRIP DALLAS Chief Operating Officer 100,000 $1.42 $141,500
2025-10-20 EITAN YARON I Director 125,000 $0.00 $0
2025-10-20 SHIV SAGIV Director 75,000 $0.00 $0
2025-10-20 CALABRESE JENNIFER ROSARIO Director 50,000 $0.00 $0
2025-10-20 LAMENDOLA DAMIEN Chief Executive Officer 550,000 $0.00 $0
2025-10-20 JOHNSON STEVE ANDREW Chief Financial Officer 275,000 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Revenue
37.16
+52.64%
24.34
+71.10%
14.23
Operating Revenue
37.16
+52.64%
24.34
+71.10%
14.23
Cost Of Revenue
24.24
+41.45%
17.14
+66.54%
10.29
Reconciled Cost Of Revenue
22.74
+37.49%
16.54
+62.30%
10.19
Gross Profit
12.92
+79.25%
7.21
+83.01%
3.94
Operating Expense
39.29
+15.93%
33.89
+71.17%
19.80
Research And Development
1.31
-64.63%
3.71
+113.85%
1.73
Selling General And Administration
25.77
+33.84%
19.26
+47.89%
13.02
Selling And Marketing Expense
6.60
-4.92%
6.94
+39.74%
4.97
General And Administrative Expense
19.18
+55.68%
12.32
+52.92%
8.06
Other Gand A
19.18
+55.68%
12.32
+52.92%
8.06
Other Operating Expenses
8.31
+12.47%
7.39
+139.64%
3.08
Total Expenses
63.53
+24.50%
51.03
+69.59%
30.09
Operating Income
-26.37
+1.16%
-26.68
-68.23%
-15.86
Total Operating Income As Reported
-27.98
-3.78%
-26.96
-69.95%
-15.86
EBITDA
-22.12
+2.08%
-22.59
-65.51%
-13.65
Normalized EBITDA
-20.49
+8.18%
-22.31
-63.73%
-13.63
Reconciled Depreciation
5.40
+30.49%
4.14
+100.65%
2.06
EBIT
-27.51
-2.96%
-26.72
-70.13%
-15.71
Total Unusual Items
-1.63
-495.54%
-0.27
-1346.95%
-0.02
Total Unusual Items Excluding Goodwill
-1.63
-495.54%
-0.27
-1346.95%
-0.02
Special Income Charges
-1.60
-486.65%
-0.27
0.00
Impairment Of Capital Assets
3.02
0.00
Net Income
-28.75
-8.63%
-26.47
-65.58%
-15.98
Pretax Income
-29.04
-7.60%
-26.99
-67.27%
-16.13
Net Non Operating Interest Income Expense
-1.53
-472.55%
-0.27
+37.55%
-0.43
Interest Expense Non Operating
1.53
+472.55%
0.27
-37.55%
0.43
Net Interest Income
-1.53
-472.55%
-0.27
+37.55%
-0.43
Interest Expense
1.53
+472.55%
0.27
-37.55%
0.43
Other Income Expense
-1.14
-2803.61%
-0.04
-125.60%
0.15
Other Non Operating Income Expenses
0.49
+108.50%
0.23
+35.92%
0.17
Gain On Sale Of Security
-0.03
-7233.80%
-0.00
+98.09%
-0.02
Gain On Sale Of Business
1.75
0.00
Tax Provision
-0.29
+44.33%
-0.52
-247.42%
-0.15
Tax Rate For Calcs
0.00
-47.37%
0.00
+111.11%
0.00
Tax Effect Of Unusual Items
-0.02
-213.44%
-0.01
-2954.66%
-0.00
Net Income Including Noncontrolling Interests
-28.75
-8.63%
-26.47
-65.58%
-15.98
Net Income From Continuing Operation Net Minority Interest
-28.75
-8.63%
-26.47
-65.58%
-15.98
Net Income From Continuing And Discontinued Operation
-28.75
-8.63%
-26.47
-65.58%
-15.98
Net Income Continuous Operations
-28.75
-8.63%
-26.47
-65.58%
-15.98
Normalized Income
-27.14
-3.58%
-26.20
-64.10%
-15.97
Net Income Common Stockholders
-28.75
-8.63%
-26.47
-65.58%
-15.98
Diluted EPS
-4.14
+20.99%
-5.24
+17.61%
-6.36
Basic EPS
-4.14
+20.99%
-5.24
+17.61%
-6.36
Basic Average Shares
6.95
+37.39%
5.06
+100.86%
2.52
Diluted Average Shares
6.95
+37.39%
5.06
+100.86%
2.52
Diluted NI Availto Com Stockholders
-28.75
-8.63%
-26.47
-65.58%
-15.98
Depreciation Amortization Depletion Income Statement
3.90
+10.13%
3.54
+80.36%
1.96
Depreciation And Amortization In Income Statement
3.90
+10.13%
3.54
+80.36%
1.96
Gain On Sale Of PPE
-0.34
-22.56%
-0.27
0.00
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Total Assets
31.68
-36.58%
49.95
+13.00%
44.20
Current Assets
17.08
-35.62%
26.54
-1.68%
26.99
Cash Cash Equivalents And Short Term Investments
1.15
-91.67%
13.76
-28.25%
19.18
Cash And Cash Equivalents
1.15
-91.67%
13.76
-28.25%
19.18
Receivables
2.70
+48.56%
1.82
+476.97%
0.32
Accounts Receivable
1.13
-21.74%
1.44
+588.72%
0.21
Gross Accounts Receivable
1.15
-21.32%
1.46
+599.96%
0.21
Allowance For Doubtful Accounts Receivable
-0.02
-4.94%
-0.02
0.00
Other Receivables
1.58
+313.85%
0.38
+257.85%
0.11
Prepaid Assets
0.74
Restricted Cash
12.34
+31.99%
9.35
+38.54%
6.75
Other Current Assets
0.89
-44.35%
1.60
+115.57%
0.74
Total Non Current Assets
14.59
-37.66%
23.41
+36.04%
17.21
Net PPE
2.98
-44.21%
5.35
+82.30%
2.93
Gross PPE
3.13
-47.74%
6.00
+85.73%
3.23
Accumulated Depreciation
-0.15
+76.78%
-0.65
-119.82%
-0.30
Properties
0.00
0.00
0.00
Machinery Furniture Equipment
0.62
-38.39%
1.01
+194.85%
0.34
Other Properties
2.51
-40.78%
4.24
+87.32%
2.27
Leases
0.00
-100.00%
0.75
+19.94%
0.62
Goodwill And Other Intangible Assets
10.32
-38.37%
16.75
+17.99%
14.20
Goodwill
3.02
-48.30%
5.84
+144.95%
2.38
Other Intangible Assets
7.30
-33.06%
10.91
-7.62%
11.81
Non Current Prepaid Assets
1.27
-2.05%
1.29
+2373.68%
0.05
Other Non Current Assets
0.02
+0.00%
0.02
-23.52%
0.03
Total Liabilities Net Minority Interest
45.12
+2.97%
43.82
+202.32%
14.49
Current Liabilities
20.84
+20.06%
17.36
+55.76%
11.15
Payables And Accrued Expenses
17.84
+24.49%
14.33
+72.65%
8.30
Payables
4.65
+218.22%
1.46
+29.33%
1.13
Accounts Payable
4.65
+218.92%
1.46
+29.47%
1.13
Current Accrued Expenses
13.19
+2.49%
12.87
+79.47%
7.17
Pensionand Other Post Retirement Benefit Plans Current
1.20
-16.13%
1.43
+59.74%
0.90
Current Debt And Capital Lease Obligation
0.51
-60.92%
1.31
+67.15%
0.78
Current Capital Lease Obligation
0.51
-60.92%
1.31
+67.15%
0.78
Current Deferred Liabilities
0.66
+129.06%
0.29
-75.24%
1.17
Current Deferred Revenue
0.66
+129.06%
0.29
-75.24%
1.17
Other Current Liabilities
0.63
+158.82%
0.24
-41.76%
0.42
Total Non Current Liabilities Net Minority Interest
24.27
-8.24%
26.46
+690.22%
3.35
Long Term Debt And Capital Lease Obligation
3.68
-22.80%
4.77
+266.55%
1.30
Long Term Capital Lease Obligation
3.68
-22.80%
4.77
+266.55%
1.30
Non Current Deferred Liabilities
1.19
-19.61%
1.48
-26.04%
2.00
Non Current Deferred Taxes Liabilities
1.19
-19.61%
1.48
-26.04%
2.00
Other Non Current Liabilities
19.40
-3.97%
20.20
+44797.11%
0.04
Stockholders Equity
-13.44
-319.07%
6.13
-79.35%
29.71
Common Stock Equity
-13.44
-319.07%
6.13
-79.35%
29.71
Capital Stock
0.00
+49.62%
0.00
-73.79%
0.00
Common Stock
0.00
+49.62%
0.00
-73.79%
0.00
Share Issued
7.96
+49.65%
5.32
+4.82%
5.07
Ordinary Shares Number
7.96
+49.65%
5.32
+4.82%
5.07
Additional Paid In Capital
63.31
+16.96%
54.13
+5.65%
51.23
Retained Earnings
-76.75
-59.91%
-47.99
-122.96%
-21.53
Total Equity Gross Minority Interest
-13.44
-319.07%
6.13
-79.35%
29.71
Total Capitalization
-13.44
-319.07%
6.13
-79.35%
29.71
Working Capital
-3.76
-140.94%
9.18
-42.08%
15.85
Invested Capital
-13.44
-319.07%
6.13
-79.35%
29.71
Total Debt
4.20
-31.02%
6.08
+191.57%
2.09
Capital Lease Obligations
4.20
-31.02%
6.08
+191.57%
2.09
Net Tangible Assets
-23.76
-123.85%
-10.61
-168.42%
15.51
Tangible Book Value
-23.76
-123.85%
-10.61
-168.42%
15.51
Dueto Related Parties Current
0.00
-100.00%
0.00
-11.99%
0.00
Line Item Trend 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-15.75
+55.31%
-35.24
-226.43%
-10.80
Cash Flow From Continuing Operating Activities
-15.75
+55.31%
-35.24
-226.43%
-10.80
Net Income From Continuing Operations
-28.75
-8.63%
-26.47
-65.58%
-15.98
Depreciation Amortization Depletion
5.40
+30.49%
4.14
+100.65%
2.06
Depreciation
1.84
+84.89%
1.00
-51.68%
2.06
Amortization Cash Flow
3.56
+13.23%
3.14
Depreciation And Amortization
5.40
+30.49%
4.14
+100.65%
2.06
Amortization Of Intangibles
3.56
+13.23%
3.14
Other Non Cash Items
1.61
+440.19%
0.30
-36.40%
0.47
Stock Based Compensation
2.10
-32.42%
3.11
+152.31%
1.23
Asset Impairment Charge
3.02
0.00
Deferred Tax
-0.29
+44.33%
-0.52
-247.42%
-0.15
Deferred Income Tax
-0.29
+44.33%
-0.52
-247.42%
-0.15
Operating Gains Losses
-1.17
-528.62%
0.27
Gain Loss On Investment Securities
0.24
Change In Working Capital
2.34
+114.59%
-16.06
-1117.11%
1.58
Change In Receivables
-0.08
+84.48%
-0.54
-336.03%
-0.12
Changes In Account Receivables
-0.11
+82.35%
-0.60
-354.00%
-0.13
Change In Prepaid Assets
0.74
-17.44%
0.89
+357.29%
-0.35
Change In Payables And Accrued Expense
3.24
+122.04%
-14.70
-762.80%
2.22
Change In Accrued Expense
0.05
+100.35%
-14.88
-711.66%
2.43
Change In Payable
3.19
+1684.67%
0.18
+183.24%
-0.21
Change In Account Payable
3.19
+1658.84%
0.18
+614.17%
0.03
Change In Other Current Assets
0.00
-100.00%
0.01
+123.53%
-0.03
Change In Other Current Liabilities
-1.55
+10.40%
-1.73
-1136.61%
-0.14
Investing Cash Flow
1.03
-96.83%
32.42
+236.20%
9.64
Cash Flow From Continuing Investing Activities
1.03
-96.83%
32.42
+236.20%
9.64
Net PPE Purchase And Sale
0.03
+107.42%
-0.36
-32.67%
-0.27
Purchase Of PPE
0.00
+100.00%
-0.36
-32.67%
-0.27
Sale Of PPE
0.03
0.00
0.00
Capital Expenditure
-0.97
+44.52%
-1.74
Capital Expenditure Reported
0.00
+100.00%
-0.60
+58.82%
-1.46
Net Business Purchase And Sale
1.00
0.00
Gain Loss On Sale Of Business
-1.75
0.00
Net Intangibles Purchase And Sale
0.00
+100.00%
-0.00
Purchase Of Intangibles
0.00
+100.00%
-0.00
Net Other Investing Changes
33.39
+193.29%
11.38
Financing Cash Flow
5.10
+2600186.73%
0.00
-100.00%
25.27
Cash Flow From Continuing Financing Activities
5.10
+2600186.73%
0.00
-100.00%
25.27
Net Issuance Payments Of Debt
0.00
+100.00%
-0.23
Issuance Of Debt
0.00
-100.00%
3.55
Repayment Of Debt
0.00
+100.00%
-3.78
Long Term Debt Issuance
0.00
-100.00%
0.55
Long Term Debt Payments
0.00
+100.00%
-0.78
Net Long Term Debt Issuance
0.00
+100.00%
-0.23
Short Term Debt Issuance
0.00
-100.00%
3.00
Short Term Debt Payments
0.00
+100.00%
-3.00
Net Short Term Debt Issuance
0.00
0.00
Net Common Stock Issuance
6.73
0.00
-100.00%
25.38
Proceeds From Stock Option Exercised
0.03
+16541.84%
0.00
-99.98%
0.95
Net Other Financing Charges
-1.66
-0.83
Changes In Cash
-9.63
-241.76%
-2.82
-111.68%
24.12
Beginning Cash Position
23.12
-10.86%
25.93
+1326.55%
1.82
End Cash Position
13.49
-41.64%
23.12
-10.86%
25.93
Free Cash Flow
-15.75
+56.50%
-36.20
-188.82%
-12.54
Common Stock Issuance
6.73
0.00
-100.00%
25.38
Issuance Of Capital Stock
6.73
0.00
-100.00%
25.38
Sale Of Business
1.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category